• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗前淋巴细胞与单核细胞比值及血小板与淋巴细胞比值对鼻咽癌患者生存的预测价值

Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients.

作者信息

Chen Yibiao, Sun Jianda, Hu Dan, Zhang Jian, Xu Yuyun, Feng Huiting, Chen Zhijie, Luo Yi, Lou Yunlong, Wu Heming

机构信息

Department of Radiation Oncology, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.

Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.

出版信息

Cancer Manag Res. 2021 Nov 23;13:8767-8779. doi: 10.2147/CMAR.S338394. eCollection 2021.

DOI:10.2147/CMAR.S338394
PMID:34866938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8633848/
Abstract

OBJECTIVE

The present study aimed to investigate the predictive value of some indexes, such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic inflammatory response index (SIRI), and systemic immune-inflammatory index (SII) in the survival of nasopharyngeal carcinoma (NPC) and provide reference for the treatment.

METHODS

A retrospective analysis was performed on 216 patients from 2016 to 2018. The cutoff values of these indexes were determined by the receiver operating characteristic (ROC) curve. The prognostic value of the indexes was evaluated according to the rate of overall survival (OS), regional recurrence-free survival (RRFS), locoregional recurrence-free survival (LRRFS), and distant metastasis-free survival (DMFS).

RESULTS

The survival analysis showed that NLR ≤2.695 (P = 0.017) and PLR ≤140.065 (P = 0.041) were associated with poor OS; however, the LMR and SIRI showed no significant statistical significance. NLR ≤2.045 (P = 0.018) and PLR ≤125.605 (P = 0.003) were associated with poor RRFS, LMR ≤2.535 (P = 0.027) and PLR ≤140.065 (P = 0.009) were associated with poor DMFS, NLR ≤2.125 (P = 0.018) and PLR ≤132.645 (P = 0.026) were associated with poor LRRFS, respectively. Logistic regression analysis showed that low LMR (≤2.535) was significantly inferior in OS (HR 23.085, 95% CI 3.425-155.622, P = 0.001) and DMFS (HR 22.839, 95% CI 4.096-127.343, P < 0.001). Moreover, low PLR (≤140.065) remained significantly related to worse OS (HR 11.908, 95% CI 1.295-109.517, P = 0.029) and DMFS (HR 9.556, 95% CI 1.448-63.088, P = 0.019).

CONCLUSION

The index LMR and PLR can be used for predicting survival in NPC patients.

摘要

目的

本研究旨在探讨中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、淋巴细胞与单核细胞比值(LMR)、全身炎症反应指数(SIRI)和全身免疫炎症指数(SII)等指标对鼻咽癌(NPC)患者生存的预测价值,为治疗提供参考。

方法

对2016年至2018年的216例患者进行回顾性分析。通过受试者工作特征(ROC)曲线确定这些指标的临界值。根据总生存(OS)率、区域无复发生存(RRFS)率、局部区域无复发生存(LRRFS)率和远处转移无复发生存(DMFS)率评估这些指标的预后价值。

结果

生存分析显示,NLR≤2.695(P = 0.017)和PLR≤140.065(P = 0.041)与较差的OS相关;然而,LMR和SIRI无显著统计学意义。NLR≤2.045(P = 0.018)和PLR≤125.605(P = 0.003)与较差的RRFS相关,LMR≤2.535(P = 0.027)和PLR≤140.065(P = 0.009)与较差的DMFS相关,NLR≤2.125(P = 0.018)和PLR≤132.645(P = 0.026)分别与较差的LRRFS相关。Logistic回归分析显示,低LMR(≤2.535)在OS(HR 23.085,95%CI 3.425 - 155.622,P = 0.001)和DMFS(HR 22.839,95%CI 4.096 - 127.343,P < 0.001)方面显著较差。此外,低PLR(≤140.065)仍与较差的OS(HR 11.908,95%CI 1.295 - 109.517,P = 0.029)和DMFS(HR 9.556,95%CI 1.448 - 63.088,P = 0.019)显著相关。

结论

LMR和PLR指标可用于预测NPC患者的生存情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/5ea57b9ec3a9/CMAR-13-8767-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/f7327f982673/CMAR-13-8767-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/b881fcbb1139/CMAR-13-8767-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/7b2b35cdb317/CMAR-13-8767-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/cb882c70b578/CMAR-13-8767-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/5ea57b9ec3a9/CMAR-13-8767-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/f7327f982673/CMAR-13-8767-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/b881fcbb1139/CMAR-13-8767-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/7b2b35cdb317/CMAR-13-8767-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/cb882c70b578/CMAR-13-8767-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a4/8633848/5ea57b9ec3a9/CMAR-13-8767-g0005.jpg

相似文献

1
Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients.治疗前淋巴细胞与单核细胞比值及血小板与淋巴细胞比值对鼻咽癌患者生存的预测价值
Cancer Manag Res. 2021 Nov 23;13:8767-8779. doi: 10.2147/CMAR.S338394. eCollection 2021.
2
Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.中性粒细胞与淋巴细胞比值和单核细胞与嗜酸性粒细胞比值作为晚期鼻咽癌的预后指标。
Eur Arch Otorhinolaryngol. 2024 Apr;281(4):1971-1989. doi: 10.1007/s00405-024-08474-7. Epub 2024 Feb 5.
3
Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.联合预处理中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值预测非转移性鼻咽癌患者的生存和预后:一项回顾性研究。
Sci Rep. 2024 Apr 30;14(1):9898. doi: 10.1038/s41598-024-59131-2.
4
[Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].[直肠癌患者术前炎症指标与预后的关系及预后列线图预测模型的建立]
Zhonghua Zhong Liu Za Zhi. 2022 May 23;44(5):402-409. doi: 10.3760/cma.j.cn112152-20200630-00612.
5
The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.急性缺血性脑卒中患者中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、淋巴细胞与单核细胞比值及全身炎症反应指数与短期功能预后的相关性
J Inflamm Res. 2023 Aug 23;16:3619-3630. doi: 10.2147/JIR.S418106. eCollection 2023.
6
The Association of Pretreatment Systemic Immune Inflammatory Response Index (SII) and Neutrophil-to-Lymphocyte Ratio (NLR) with Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma.甲状腺乳头状癌患者治疗前全身免疫炎症反应指数(SII)和中性粒细胞与淋巴细胞比值(NLR)与淋巴结转移的相关性
Int J Gen Med. 2024 Jul 1;17:2887-2897. doi: 10.2147/IJGM.S461708. eCollection 2024.
7
Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.调强放疗时代鼻咽癌患者炎症标志物的预后价值
Cancer Manag Res. 2021 Aug 31;13:6799-6810. doi: 10.2147/CMAR.S311094. eCollection 2021.
8
A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.一项大型队列研究揭示了外周血淋巴细胞与单核细胞比值升高与鼻咽癌良好预后之间的关联。
PLoS One. 2013 Dec 27;8(12):e83069. doi: 10.1371/journal.pone.0083069. eCollection 2013.
9
Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.免疫治疗相关炎症指标的预测价值:免疫检查点抑制剂治疗鼻咽癌患者的动态变化。
Ann Med. 2023;55(2):2280002. doi: 10.1080/07853890.2023.2280002. Epub 2023 Dec 8.
10
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.系统免疫炎症指数、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值可预测纳武利尤单抗治疗转移性非小细胞肺癌患者的临床结局。
J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8.

引用本文的文献

1
Integrating pan-immune-inflammation value into personalized survival prediction of nasopharyngeal carcinoma: a large-scale long-term retrospective study.将泛免疫炎症值纳入鼻咽癌个性化生存预测:一项大规模长期回顾性研究
BMC Cancer. 2025 Jul 21;25(1):1194. doi: 10.1186/s12885-025-14413-4.
2
Prognostic value of immune-inflammatory and nutrition indicators in non-metastatic nasopharyngeal carcinoma with negative plasma Epstein-Barr virus DNA.血浆EB病毒DNA阴性的非转移性鼻咽癌中免疫炎症和营养指标的预后价值
Ther Adv Med Oncol. 2024 Oct 14;16:17588359241286489. doi: 10.1177/17588359241286489. eCollection 2024.
3

本文引用的文献

1
Nomogram Based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma.基于乳酸脱氢酶与白蛋白比值(LAR)和血小板与淋巴细胞比值(PLR)的列线图预测鼻咽癌患者的生存率
J Inflamm Res. 2021 Aug 20;14:4019-4033. doi: 10.2147/JIR.S322475. eCollection 2021.
2
The potential prognostic role of peritumoral eosinophils within whole tumor-associated inflammatory cells and stromal histological characteristics in colorectal cancer.结直肠癌中肿瘤周围嗜酸性粒细胞与肿瘤相关炎症细胞及基质组织学特征对预后的潜在作用。
Pol J Pathol. 2020;71(3):207-220. doi: 10.5114/pjp.2020.99787.
3
Prognostic Study of Inflammatory Markers in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy.
接受调强放疗的鼻咽癌患者炎症标志物的预后研究
Cancer Manag Res. 2024 Sep 30;16:1321-1328. doi: 10.2147/CMAR.S481142. eCollection 2024.
4
Prognostic Value of Pre-Chemoradiotherapy Pan-Immune-Inflammation Value (PIV) in Locally Advanced Nasopharyngeal Cancers.局部晚期鼻咽癌患者放化疗前的 Pan-Immune-Inflammation 值的预后价值。
Cancer Control. 2024 Jan-Dec;31:10732748241290746. doi: 10.1177/10732748241290746.
5
Pretreatment System Inflammation Response Index (SIRI) is a Valuable Marker for Evaluating the Efficacy of Neoadjuvant Therapy in Breast Cancer Patients.治疗前系统炎症反应指数(SIRI)是评估乳腺癌患者新辅助治疗疗效的重要指标。
Int J Gen Med. 2024 Sep 25;17:4359-4368. doi: 10.2147/IJGM.S478000. eCollection 2024.
6
Monocyte-to-lymphocyte ratio is a prognostic predictor for patients with non-small cell lung cancer treated with stereotactic body radiation therapy.单核细胞与淋巴细胞比值是接受立体定向体部放疗的非小细胞肺癌患者的预后预测指标。
Rep Pract Oncol Radiother. 2024 Jun 6;29(2):228-235. doi: 10.5603/rpor.100168. eCollection 2024.
7
Clinical implications of the serum platelet-to-lymphocyte ratio in the modern radiation oncology era: research update and literature review.血清血小板与淋巴细胞比值在现代放射肿瘤学时代的临床意义:研究更新与文献回顾。
Radiat Oncol. 2024 Aug 13;19(1):107. doi: 10.1186/s13014-024-02485-8.
8
A Nomogram Based on Platelet Distribution Width-to-Lymphocyte Ratio to Predict Overall Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.基于血小板分布宽度与淋巴细胞比值的列线图预测局部晚期鼻咽癌患者的总生存期
J Inflamm Res. 2024 Jul 3;17:4297-4308. doi: 10.2147/JIR.S462833. eCollection 2024.
9
Value of Platelet to Lymphocyte Ratio in Nasopharyngeal Carcinoma Various Stages.血小板与淋巴细胞比值在鼻咽癌各分期中的价值
Iran J Otorhinolaryngol. 2024 May;36(3):467-473. doi: 10.22038/IJORL.2024.75070.3523.
10
Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.基于随机生存森林建立的甘油三酯-炎症评分预测鼻咽癌患者生存:一项回顾性研究。
Front Immunol. 2024 Apr 26;15:1375931. doi: 10.3389/fimmu.2024.1375931. eCollection 2024.
Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.
鼻咽癌靶向治疗的研究进展主要基于信号通路。
Signal Transduct Target Ther. 2020 Oct 23;5(1):245. doi: 10.1038/s41392-020-00340-2.
4
Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome.肿瘤浸润 T 淋巴细胞与肠型胃癌分子亚型及预后的关系。
Virchows Arch. 2021 Apr;478(4):707-717. doi: 10.1007/s00428-020-02932-3. Epub 2020 Sep 21.
5
Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer.抑制中性粒细胞依赖性血管生成可消除结直肠癌遗传模型中对抗血管内皮生长因子抗体的耐药性。
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21598-21608. doi: 10.1073/pnas.2008112117. Epub 2020 Aug 19.
6
Platelet-Leukocyte Interplay in Cancer Development and Progression.血小板-白细胞相互作用在癌症发生和发展中的作用。
Cells. 2020 Apr 1;9(4):855. doi: 10.3390/cells9040855.
7
The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer.术前全身炎症反应指数(SIRI)可独立预测绝经后乳腺癌患者的生存情况。
Curr Probl Cancer. 2020 Aug;44(4):100560. doi: 10.1016/j.currproblcancer.2020.100560. Epub 2020 Feb 24.
8
Interplay between inflammation and cancer.炎症与癌症的相互作用。
Adv Protein Chem Struct Biol. 2020;119:199-245. doi: 10.1016/bs.apcsb.2019.09.004. Epub 2019 Nov 26.
9
Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.全身炎症反应指数(SIRI)对头颈部鳞状细胞癌患者的预后评估能力
Head Neck. 2020 Feb;42(2):336-343. doi: 10.1002/hed.26010. Epub 2019 Nov 21.
10
Platelet-to-lymphocyte ratio as a potential prognostic factor in nasopharyngeal carcinoma: A meta-analysis.血小板与淋巴细胞比值作为鼻咽癌潜在预后因素的Meta分析
Medicine (Baltimore). 2019 Sep;98(38):e17176. doi: 10.1097/MD.0000000000017176.